Unveiling the Hidden Risks: An Update Decade-Long Analysis of Abraxane-Related Adverse Events from the FAERS Database
Our results re-emphasize the importance of a robust Post Marketing Surveillance system and suggest this FAERS database based analysis provides an updated, independent information on Abraxane related AEs to enrich its safety profile. A process of continuous vigilance and additional investigations on specific areas that may have some undesired events are imperative to increase our knowledge on how Abraxane should be handled in terms of its safety.
Authors
- Yan Jiao (ORCID: https://orcid.org/0000-0001-6914-7949)
- Yan Shen (ORCID: https://orcid.org/0000-0002-7883-5169)
- Yue‐Chen Zhao (ORCID: https://orcid.org/0000-0002-7098-5322)
- Xin Li (ORCID: https://orcid.org/0000-0003-4308-1229)
- Tiejun Wang (ORCID: https://orcid.org/0000-0002-2362-8007)
- Chao-He Zhang
- Chaoqun Wang (ORCID: https://orcid.org/0000-0002-4649-5518)
Institutions
- Jilin University (CN)
- First Hospital of Jilin University (CN)
- Second Affiliated Hospital of Jilin University (CN)
- Aviation General Hospital (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2024-11-01
- DOI
- https://doi.org/10.2147/ijn.s490400
- Citations
- 9
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 2.54
Funders
- People's Government of Jilin Province